CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 194 enrolled
Drug / intervention
Morphine +1 moredrug
Likely dose
Morphine 0.05 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00305058
NCT00305058Phase 3Completed
CompareCT.gov

A Randomized Clinical Trial Comparing Intravenous Morphine and Intravenous Hydromorphone in the Treatment of Adult ED Patients With Moderate to Severe Pain

Montefiore Medical Center·interventional·Posted Mar 21, 2006·Updated Aug 20, 2018

In Brief

A Phase 3 clinical trial evaluating Morphine and Hydromorphone for Acute Pain. Completed, enrolled 194 participants across 1 site.

Detailed Summary

The purpose of this research study is to determine which opiate pain medication (morphine or hydromorphone (Dilaudid)) is more effective in the treatment of acute pain in patients presenting to the emergency department.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Pain
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 21, 2006
Enrollment StartJul 1, 2005
Primary CompletionMar 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 20.3 years ago

Interventions

Morphinedrug

0.05 mg/kg Intravenous

Hydromorphonedrug

0.0075 mg/kg intravenous